Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Wayne Kuznar
Authored Items
Evolving Immuno-Oncology Strategies in Renal-Cell Carcinoma
By
Wayne Kuznar
Articles
Web Exclusives
,
Immunotherapy
Read More ›
Personalized Neoadjuvant Immunotherapy Combinations Improve Outcomes in Stage III Melanoma
By
Wayne Kuznar
Articles
Melanoma/Skin Cancer
,
Web Exclusives
Read More ›
Personalizing Immunotherapy in NSCLC Using PD-L1 and Tumor Mutation Burden as Biomarkers
By
Wayne Kuznar
Articles
Lung Cancer
,
Web Exclusives
Read More ›
IMPACT: Matching Treatment and Molecular Testing Extends Survival in Advanced Cancer
By
Wayne Kuznar
Articles
Web Exclusives
Read More ›
NCCN Issues First Guideline for Immunotherapy-Related Adverse Events
By
Wayne Kuznar
Articles
Immunotherapy
,
Web Exclusives
Read More ›
Immunotherapy Combination Shows Durable Responses in Mismatch Repair–Deficient Metastatic Colorectal Cancer
By
Wayne Kuznar
Articles
Immunotherapy
,
Web Exclusives
,
Colorectal Cancer
Read More ›
Novel TKI Leads to Responses in Heavily Pretreated Patients with Chronic Myeloid Leukemia
By
Wayne Kuznar
Articles
Web Exclusives
,
Immunotherapy
Read More ›
CAR T-Cell Therapy Shows “Impressive” Results in Multiple Myeloma
By
Wayne Kuznar
Articles
Web Exclusives
,
Immunotherapy
Read More ›
Immunotherapy-Related Adverse Reactions: Grading of Symptoms Key to Appropriate Management
By
Wayne Kuznar
Articles
Web Exclusives
,
Immunotherapy
Read More ›
Ibrutinib plus Venetoclax Combo Elicits Impressive Responses in Relapsed Chronic Lymphocytic Leukemia
By
Wayne Kuznar
Articles
Web Exclusives
,
Leukemia
Read More ›
Daratumumab Therapy for Smoldering Myeloma Extends Progression-Free Survival
By
Wayne Kuznar
Articles
Web Exclusives
,
Multiple Myeloma
Read More ›
Lenalidomide plus Elotuzumab Maintenance Regimen Improves Responses in Multiple Myeloma
By
Wayne Kuznar
Articles
Web Exclusives
,
Multiple Myeloma
Read More ›
CAR T-Cell Immunotherapy Makes Strides in Multiple Myeloma, with Durable Remission
By
Wayne Kuznar
Articles
Web Exclusives
,
Multiple Myeloma
Read More ›
Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia
By
Wayne Kuznar
Articles
Web Exclusives
,
Emerging Therapies
Read More ›
First-in-Class Sotatercept Improves Hemoglobin Levels in Anemic Patients with Myelofibrosis
By
Wayne Kuznar
Articles
Web Exclusives
,
Emerging Therapies
Read More ›
Precision Medicine and Immunotherapy Highlighted at ASH 2017
By
Wayne Kuznar
Articles
Conference Correspondent
,
Web Exclusives
,
ASH Highlights
Read More ›
Can Metastatic Cancer with Diagnostic Ambiguity Be Treated Based on Mutational Status Alone?
By
Wayne Kuznar
Dx Profiler: Can Metastatic Cancer with Diagnostic Ambiguity Be Treated Based on Mutational Status Alone?
Read More ›
2014 Oncology Pipeline Looks Impressive
By
Wayne Kuznar
September 2014, Part 3
Emerging Therapies
Read More ›
Immunotherapy Holds Promise to Extend Survival in GI Cancers
By
Wayne Kuznar
June 2014, Part 2
Gastrointestinal Cancer
Read More ›
ASCO President Focuses on Bridges to Conquer Cancer
By
Wayne Kuznar
Articles
Editorial
Read More ›
Multiple Myeloma: Novel Agents Emerge in Initial Therapy, Refractory Setting
By
Wayne Kuznar
Articles
Multiple Myeloma
Read More ›
Ten Years of Tamoxifen Is Superior to 5 Years in ER+ Breast Cancer
By
Wayne Kuznar
Articles
Breast Cancer
Read More ›
Comprehensive Gene Analysis Allows for Personalization of 5-FU to Reduce Risk of Toxicity
By
Wayne Kuznar
Articles
Editorial
Read More ›